Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12. In ...

Full US Food and Drug Administration approval of the Pfizer/BioNTech COVID-19 vaccine is "imminent," a senior federal official told CNN on Friday -- but said no date has been mentioned. A person ...

PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...

On Tuesday, a key Food and Drug Administration (FDA) panel voted to formally recommend that children as young as 5 be authorized to receive Pfizer's COVID-19 vaccine under emergency use authorization.

Stream Connecticut News for free, 24/7, wherever you are. The new vaccines, which target the omicron variant XBB.1.5, are approved for people 12 and older and are authorized under emergency use for ...

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...